Figure 2 — Topoisomerase II-binding protein 1 promotes the progression of prostate cancer via ATR-CHK1 signaling pathway

Research Paper|Volume 12, Issue 10|pp. 9948–9958

Topoisomerase II-binding protein 1 promotes the progression of prostate cancer via ATR-CHK1 signaling pathway

100%

Figure 2.Kaplan-Meier survival curves of (A) overall survival and (B) biochemical recurrence (BCR)-free survival for TopBP1 expression in all patients with prostate cancer (PCa). (C) Non-metastatic survival and (D) BCR-free survival for TopBP1 expression in non-metastatic PCa patients.